Login / Signup

Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study.

Puyuan XingQian ZhaoLi ZhangHanping WangDingzhi HuangPei HuYinghui SunYuan-Kai Shi
Published in: BMC medicine (2022)
ClinicalTrials.gov, NCT02695550.
Keyphrases